This study focused on the hypothesis that the expression of ID1 and ID3 genes could alter some populations in the TIME, leading to an immunosuppressive microenvironment and, consequently, disease progression and non-response to treatment in B-ALL patients. This evidence concerns the gene ID1 and acute lymphoblastic leukemia.